Invega Side Effects
There have been
reported adverse effects associated with the drug
Invega | Paliperidone:
- dizziness
- extreme tiredness
- weakness
- headache
- dry mouth
- increased saliva
- weight gain
- stomach pain
Some side effects can be serious:
- fever
- muscle pain or stiffness
- confusion
- fast, pounding, or irregular heartbeat
- sweating
- unusual movements of your face or body that you cannot control
- slow or stiff movements
- restlessness
- painful erection of the penis that lasts for hours
Other more serious adverse side effects can include:
If you or a loved one has suffered from the drug
Invega | Paliperidone and have fallen victim to any of its adverse side effects, please do not hesitate to
contact someone who can help you.
Warnings & Recalls for Invega
Invega | Paliperidone is contraindicated in the following patients:
- In patients with a known hypersensitivity to paliperidone, risperidone, or any active component of Invega | Paliperidone
- Cerebrovascular adverse events (strokes, transient ischemia attacks).
- Neuroleptic Malignant Syndrome (NMS)
- QT Prolongation
- Hyperglycemia
- Diabetes
- Dyslipidemia
- Hyperprolactinemia
- In patients with pre-existing gastrointestinal problems
- Orthostatic Hypotension
- Fainting
- Leukopenia
- Neutropenia
- Agranulocytosis
- In patients who are suicidal
There is an associated “black box” warning sponsored by the FDA regarding
Invega | Paliperidone. As it relates to the oral tablet formulation (extended release), elderly patients with dementia-related psychosis treated with a drug such as
Invega | Paliperidone are at an increased risk of death compared with placebo. The causes of death may vary, but they were either cardiovascular or infection (notably pneumonia).
If you or a loved one has suffered from the drug
Invega | Paliperidone and have fallen victim to any of its adverse side effects, please do not hesitate to
contact someone who can help you.
Invega Treatment and Use
Invega | Paliperidone is a drug that’s also known as 9-hydroxyrisperidone, and is an antipsychotic which has been developed by the company Janssen Pharmaceutica. This drug has been formulated exclusively for schizophrenia and schizoaffective disorder. Invega is meant to be an extended release formulation of paliperidone that uses OROS extended-release system, which in turn allows for once-daily dosing of this drug. Invega | Paliperidone can also come in a long-acting injectable formulation that is primarily used for getting out of a manic episode and this drug can be used at lower doses for treatment of bipolar disorder.
The FDA has approved Invega | Paliperidone’s “Sustenna” formulation also for the treatment of schizophrenia.
It is worth noting that the revenue attributed for Invega | Paliperidone has been about $425 million.
There is an associated “black box” warning sponsored by the FDA regarding Invega | Paliperidone. As it relates to the oral tablet formulation (extended release), elderly patients with dementia-related psychosis treated with a drug such as Invega | Paliperidone are at an increased risk of death compared with placebo. The causes of death may vary, but they were either cardiovascular or infection (notably pneumonia).
If you or a loved one has suffered from the drug Invega | Paliperidone and have fallen victim to any of its adverse side effects, please do not hesitate to contact someone who can help you.
Other Names for Invega
Paliperidone
Lawsuits & Legal Information for Invega
